HHS Recovery Act Recipient Reporting Readiness Tool
Step 3. Select A Grant Award
Review the list of awards and select the Award Title link to see the required reporting data.
| DUNS Number | Award Number | Award Title | Agency | Fiscal Year | Issue Date | Funding Amount |
| 191510239 | 1C06RR030016-01 | CONSTRUCTION OF NEW ANIMAL FACILITY ANNEX FOR WEST VIRGINIA UNIVERSITY | NIH | 2010 | 03-04-2010 | $ 14,590,939 |
| 191510239 | 1R01GM088839-01A1 | DE NOVO SYNTHESIS FOR MEDCHEM ON SUGARS | NIH | 2009 | 08-11-2009 | $ 293,000 |
| 191510239 | 1R01HL091456-01 | WC-CO NANOPARTICLES IN INITIATING ANGIOGENESIS BY REACTIVE OXYGEN SPECIES | NIH | 2009 | 05-29-2009 | $ 424,850 |
| 191510239 | 1R15CA150999-01 | PILOT: HOME TELEMONITORING FOR SELF MANAGEMENT EDUCATION OF PATIENTS WITH LUNG CA | NIH | 2010 | 05-21-2010 | $ 366,250 |
| 191510239 | 1R21AG031983-01A1 | INVESTIGATION OF LONGITUDINAL CONSEQUENCES OF ADVERSE EVENTS AMONG OLDER ADULTS | NIH | 2009 | 05-12-2009 | $ 179,051 |
| 191510239 | 1R21AI083424-01 | MUCOSAL DENDRITIC CELL FUNCTION FOLLOWING ENTERIC VIRUS INFECTION | NIH | 2009 | 08-28-2009 | $ 183,125 |
| 191510239 | 1R21ES014698-01A1 | PRECOCIOUS IMMUNE SENESCENCE INDUCED BY PRE- & POSTNATAL ATRAZINE EXPOSURE | NIH | 2009 | 05-13-2009 | $ 219,750 |
| 191510239 | 1R21ES017237-01 | ANALYSIS OF ARSENIC IN INDUCING ROS, SIGNALING PATHWAYS, AND LUNG CARCINOGENESIS | NIH | 2009 | 05-13-2009 | $ 183,125 |
| 191510239 | 1R21NS061103-01A1 | PLASTICITY IN DEEP CEREBELLAR NUCLEI AS A FUNCTION OF CLASSICAL CONDITIONING | NIH | 2009 | 05-13-2009 | $ 204,075 |
| 191510239 | 1RC1ES018274-01 | MICROVASCULAR HEALTH AND NANOPARTICLE EXPOSURE | NIH | 2009 | 09-23-2009 | $ 499,999 |
| 191510239 | 1RC1MH088480-01 | PHOSPHODIESTERASE-2 AND MOOD DISORDERS: TARGET VALIDATION AND DRUG DISCOVERY | NIH | 2009 | 09-28-2009 | $ 483,316 |
| 191510239 | 1S10RR026378-01 | VISUAL SONICS VEVO 2100 IMAGING SYSTEM | NIH | 2010 | 03-18-2010 | $ 454,415 |
| 191510239 | 2R01HL069802-04A2 | AEROBIC EXERCISE, DIET AND CHOLESTEROL: A META-ANALYSIS | NIH | 2009 | 08-12-2009 | $ 139,166 |
| 191510239 | 3DP2DK083095-01S1 | MECHANISMS OF DIABETIC CARDIOMYOPATHY: MITOCHONDRIA SUBPOPULATIONS BROUGHT TO FOC | NIH | 2010 | 12-30-2009 | $ 85,000 |
| 191510239 | 3P20RR015574-10S1 | COBRE IN SENSORY NEUROSCIENCE | NIH | 2009 | 09-15-2009 | $ 443,199 |
| 191510239 | 3P20RR015574-10S2 | COBRE IN SENSORY NEUROSCIENCE | NIH | 2009 | 09-21-2009 | $ 192,486 |
| 191510239 | 3P20RR016440-09S1 | COBRE FOR SIGNAL TRANSDUCTION AND CANCER | NIH | 2009 | 08-25-2009 | $ 1,000,000 |
| 191510239 | 3P30RR031155-01S1 | COBRE TRANSITIONAL CENTER IN NEUROSCIENCE | NIH | 2010 | 09-09-2010 | $ 420,758 |
| 191510239 | 3P30RR031155-01S2 | COBRE TRANSITIONAL CENTER IN NEUROSCIENCE | NIH | 2010 | 09-09-2010 | $ 171,759 |
| 191510239 | 3R01CA109460-04S1 | PI3K PATHWAY IN PROSTATE TUMORIGENESIS AND ANGIOGENESIS | NIH | 2009 | 06-02-2009 | $ 22,172 |
| 191510239 | 3R01DA013978-07S1 | SYNTHESIS AND EVALUATION OF SIGMA-ACTIVE COCAINE ANTAGONISTS | NIH | 2009 | 06-17-2009 | $ 19,924 |
| 191510239 | 3R01DA013978-07S2 | SYNTHESIS AND EVALUATION OF SIGMA-ACTIVE COCAINE ANTAGONISTS | NIH | 2009 | 09-15-2009 | $ 41,900 |
| 191510239 | 3R01DC007695-03S1 | DEVELOPMENT OF THE CALYX OF HELD | NIH | 2009 | 09-16-2009 | $ 480,900 |
| 191510239 | 3R01DK058034-10S1 | REGULATION OF NA-NUTRIENT CO-TRANSPORT | NIH | 2010 | 02-02-2010 | $ 100,000 |
| 191510239 | 3R01DK064668-05S1 | SKELETAL MUSCLE MICROCIRCULATION IN OBESE ZUCKER RATS | NIH | 2009 | 09-16-2009 | $ 85,837 |
| 191510239 | 3R01HL076340-04S1 | REGULATION OF FAS-MEDIATED LUNG CELL APOPTOSIS | NIH | 2009 | 07-15-2009 | $ 136,515 |
| 191510239 | 3R15CA132124-01A2S2 | CELL HETEROGENEITY AND EMERGENT TRASTUZUMAB RESISTANCE IN BREAST CANCER: CONCEPT | NIH | 2009 | 06-02-2009 | $ 39,496 |
| 191510239 | 3R25RR023274-04S1 | WEST VIRGINIA HSTA STUDENTS DESIGN PUBLIC HEALTH CLINICAL TRIALS | NIH | 2009 | 09-01-2009 | $ 226,568 |
| 191510239 | 3T32GM081741-02S1 | RESEARCH TRAINING PROGRAM IN THE BEHAVIORAL AND BIOMEDICAL SCIENCES | NIH | 2009 | 08-12-2009 | $ 154,488 |
| 191510239 | 5R01GM088839-02 | DE NOVO SYNTHESIS FOR MEDCHEM ON SUGARS | NIH | 2010 | 07-22-2010 | $ 3,254 |
| 191510239 | 5R01HL069802-05 | AEROBIC EXERCISE, DIET AND CHOLESTEROL: A META-ANALYSIS | NIH | 2010 | 06-17-2010 | $ 120,428 |
| 191510239 | 5R21AG031983-02 | INVESTIGATION OF LONGITUDINAL CONSEQUENCES OF ADVERSE EVENTS AMONG OLDER ADULTS | NIH | 2010 | 04-29-2010 | $ 148,661 |
| 191510239 | 5R21AI083424-02 | MUCOSAL DENDRITIC CELL FUNCTION FOLLOWING ENTERIC VIRUS INFECTION | NIH | 2010 | 08-16-2010 | $ 219,750 |
| 191510239 | 5R21ES014698-02 | PRECOCIOUS IMMUNE SENESCENCE INDUCED BY PRE- & POSTNATAL ATRAZINE EXPOSURE | NIH | 2010 | 04-23-2010 | $ 183,125 |
| 191510239 | 5R21ES017237-02 | ANALYSIS OF ARSENIC IN INDUCING ROS, SIGNALING PATHWAYS, AND LUNG CARCINOGENESIS | NIH | 2010 | 04-23-2010 | $ 0 |
| 191510239 | 5R21NS061103-02 | PLASTICITY IN DEEP CEREBELLAR NUCLEI AS A FUNCTION OF CLASSICAL CONDITIONING | NIH | 2010 | 04-17-2010 | $ 198,779 |
| 191510239 | 5RC1ES018274-02 | MICROVASCULAR HEALTH AND NANOPARTICLE EXPOSURE | NIH | 2010 | 07-23-2010 | $ 500,000 |
| 191510239 | 5RC1MH088480-02 | PHOSPHODIESTERASE-2 AND MOOD DISORDERS: TARGET VALIDATION AND DRUG DISCOVERY | NIH | 2010 | 08-10-2010 | $ 468,313 |
| 191510239 | D76HP20894 | ARRA - EQUIPMENT TO ENHANCE TRAINING FOR HEALTH PROFESSIONALS | HRSA | 2010 | 09-03-2010 | $ 132,513 |
| 191510239 | D76HP20956 | ARRA - EQUIPMENT TO ENHANCE TRAINING FOR HEALTH PROFESSIONALS | HRSA | 2010 | 09-05-2010 | $ 291,497 |
To continue, click on the Award Title in the list above to obtain detailed data about a specific Award.
The Award Detail screen should display with the data for that award that is available for reporting to FederalReporting.gov.
DISCLAIMER
The data contained in the HHS Recipient Readiness Tool reflects the best available data for HHS grant programs that are subject to Recovery Act Recipient Reporting. Please note that according to OMB supplemental guidance recipients are not required to report on awards less than $25,000 on FederalReporting.gov. For a list of programs that must be reported to FederalReporting.gov please visit Appendix 1 of the June 22nd OMB guidance. For additional questions or concerns on reporting requirements for your award please contact your grants management specialist.
Data are refreshed every 24 hours. Awards issued near the end of the reporting period may not be available for 72 hours pending the timeliness of HHS Agency data transmission. If you are unable to locate your data please contact your grants management specialist.
